[1]
O. Sharmeen, M. H. Rashid, M. A. Rouf, and A. Islam, “Subcutaneous Anti-D versus intravenous methylprednisolone for the treatment of immune thrombocytopenic purpura”, Int J Contemp Pediatr, vol. 5, no. 5, pp. 1719–1723, Aug. 2018.